Reply to Dr. Witjes regarding universal tumor genomic sequencing as a prescreen for germline genetic testing in patients diagnosed with ovarian cancer

• Jenny Lin,
• Melissa K. Frey

Affiliations

Jenny Lin

Weill Cornell Medicine, United States

Melissa K. Frey

Corresponding author at: Assistant Professor, Division of Gynecologic Oncology.; Weill Cornell Medicine, United States